Cellular and molecular coordination of alveolar regeneration
Active Grant Awarded
- Award ID
- R01HL189152
- Recipient
-
Vanderbilt University Medical Center UEI GYLUH9UXHDX5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $917,304
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date 6% complete
- Place of performance
- Forest Hills, TN 37215, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded Grant R01HL189152 to Vanderbilt University Medical Center on September 1, 2026, obligating $917,304 under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds research titled "Cellular and Molecular Coordination of Alveolar Regeneration," which examines how epithelial, endothelial, and mesenchymal cells re-establish spatial relationships to restore gas-exchange structures after lung injury. The project centers on semaphorin signaling and uses reversible injury models alongside spatial and single-cell transcriptomic data from human infant and adult lungs. Preliminary data indicate semaphorin signaling is disrupted in bronchopulmonary dysplasia, where AT1 semaphorin ligand and ACAP neuropilin-1 receptor expression are downregulated.
The period of performance runs through May 31, 2030, and the place of performance is Forest Hills, TN 37215.
Two sub-awards, both dated October 13, 2026, pass funding to Vanderbilt University through its Sponsored Programs Administration division (R01HL189152-154517) and to The Translational Genomics Research Institute, doing business as Tgen Research Institute (R01HL189152-154530).
Description
- Abstract
- The lung is exposed to numerous injurious stimuli throughout life, including infections, environmental particulates, toxins, and clinical interventions such as hyperoxia or barotrauma. While the lung has remarkable repair capacity, repeated injuries or insults during critical developmental periods can result in failed repair processes, permanent respiratory deficits, and chronic lung diseases. Alveolar repair requires coordinated spatial relationships between epithelial, endothelial, and mesenchymal cells to restore gas-exchange structures. However, the mechanisms that orchestrate these proximity-dependent interactions remain poorly understood, limiting the development of therapies to promote alveolar regeneration. Injury to the alveoli disrupts alveolar type 1 epithelial cells (AT1) and alveolar capillary endothelial cells (ACAPS), requiring progenitor cells to migrate, mature, and reestablish functional connections at the basement membrane to restore gas-exchange capacity. While single-cell transcriptomics has advanced our understanding of cell states during injury and repair, critical gaps remain in understanding how cellular proximity is reestablished to enable structural repair. Our novel paradigm incorporates reversible injury models, revealing pathways that promote regeneration. Preliminary spatial and single-cell transcriptomic data from human infant and adult lungs with evolving lung disease highlight semaphorin signaling as a key driver of repair. Semaphorins are conserved guidance molecules that direct cellular movements and positional relationships, facilitating signaling pathways such as BMP, WNT, and notch. Our data show semaphorin signaling is disrupted in bronchopulmonary dysplasia (BPD), where AT1 semaphorin ligand expression and acap neuropilin-1 (NRP1) receptor expression are downregulated, impairing BMP signaling and differentiation. Conversely, regenerative mouse models show preserved semaphorin signaling, while NRP1 deletion in ACAPS prevents alveolar repair. These findings support our hypothesis that semaphorin signaling restores AT1-acap proximity, enabling alveolar regeneration. We will investigate this in two specific aims: 1) characterize spatiotemporal semaphorin signaling dynamics in resolving versus persistent lung injury using human tissue, mouse models, and spatial transcriptomics. 2) determine how semaphorin signaling restores alveolar structure using genetic, molecular, and live imaging approaches in chronic injury models. This work will define semaphorin signaling in alveolar regeneration, guiding stage-specific therapeutic strategies for chronic lung diseases across the lifespan.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The Translational Genomics Research Institute | $71,309 | |
| Vanderbilt University | $25,736 |
Quick answers
Who received award R01HL189152?
R01HL189152 was awarded to Vanderbilt University Medical Center by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2026.
How much is award R01HL189152 worth?
$917,304 has been obligated on R01HL189152.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award